These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16353469)

  • 1. Prolotherapy (proliferation therapy) in the treatment of TMD.
    Hakala RV
    Cranio; 2005 Oct; 23(4):283-8. PubMed ID: 16353469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years' follow up.
    Refai H
    Br J Oral Maxillofac Surg; 2017 Jun; 55(5):465-470. PubMed ID: 28460873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation.
    Zhou H; Hu K; Ding Y
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):63-6. PubMed ID: 24064304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term results of prolotherapy in the management of temporomandibular joint dislocation.
    Ungor C; Atasoy KT; Taskesen F; Cezairli B; Dayisoylu EH; Tosun E; Senel FC
    J Craniofac Surg; 2013 Mar; 24(2):411-5. PubMed ID: 23524704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextrose Prolotherapy Versus Lidocaine Injection for Temporomandibular Dysfunction: A Pragmatic Randomized Controlled Trial.
    Zarate MA; Frusso RD; Reeves KD; Cheng AL; Rabago D
    J Altern Complement Med; 2020 Nov; 26(11):1064-1073. PubMed ID: 32780636
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial.
    Cömert Kiliç S; Kiliç N; Güngörmüş M
    J Oral Maxillofac Surg; 2023 Apr; 81(4):389-395. PubMed ID: 36693543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta-analysis.
    Nagori SA; Jose A; Gopalakrishnan V; Roy ID; Chattopadhyay PK; Roychoudhury A
    J Oral Rehabil; 2018 Dec; 45(12):998-1006. PubMed ID: 30024045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment.
    Fouda AA
    Br J Oral Maxillofac Surg; 2018 Oct; 56(8):715-718. PubMed ID: 30107954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial.
    Cömert Kiliç S; Güngörmüş M
    Int J Oral Maxillofac Surg; 2016 Jul; 45(7):813-9. PubMed ID: 26846795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Efficacy of Different Concentrations of Dextrose Prolotherapy in Temporomandibular Joint Hypermobility Treatment.
    Mustafa R; Güngörmüş M; Mollaoğlu N
    J Craniofac Surg; 2018 Jul; 29(5):e461-e465. PubMed ID: 29533255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of hypertonic dextrose injection (prolotherapy) in temporomandibular joint dysfunction: a systematic review and meta-analysis.
    Sit RW; Reeves KD; Zhong CC; Wong CHL; Wang B; Chung VC; Wong SY; Rabago D
    Sci Rep; 2021 Jul; 11(1):14638. PubMed ID: 34282199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prolotherapy in temporomandibular joint disorder: a quality of life assessment.
    Dasukil S; Arora G; Shetty S; Degala S
    Br J Oral Maxillofac Surg; 2021 Jun; 59(5):599-604. PubMed ID: 33750579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders.
    Andre A; Kang J; Dym H
    Oral Maxillofac Surg Clin North Am; 2022 Feb; 34(1):49-59. PubMed ID: 34598856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: A randomized, double-blind clinical study.
    Haggag MA; Al-Belasy FA; Said Ahmed WM
    J Craniomaxillofac Surg; 2022 May; 50(5):426-431. PubMed ID: 35501215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.
    Stoll ML; Good J; Sharpe T; Beukelman T; Young D; Waite PD; Cron RQ
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1802-7. PubMed ID: 22265164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging intra-articular drug delivery systems for the temporomandibular joint.
    Mountziaris PM; Kramer PR; Mikos AG
    Methods; 2009 Feb; 47(2):134-40. PubMed ID: 18835358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study.
    Dasukil S; Shetty SK; Arora G; Degala S
    J Maxillofac Oral Surg; 2021 Mar; 20(1):115-120. PubMed ID: 33584052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of superoxide dismutase (SOD) in patients with temporomandibular joint dysfunction--a preliminary study.
    Lin Y; Pape HD; Friedrich R
    Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 2):428-9. PubMed ID: 7890991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of histological changes found in a mechanical arthropatic temporomandibular joint (TMJ) exposed to an intra-articular Hyaluronic acid (HA) injection, in a rat model.
    El-Hakim IE; Elyamani AO
    J Craniomaxillofac Surg; 2011 Dec; 39(8):610-4. PubMed ID: 21216612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.
    Stoll ML; Morlandt AB; Teerawattanapong S; Young D; Waite PD; Cron RQ
    Rheumatology (Oxford); 2013 Mar; 52(3):554-9. PubMed ID: 23221325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.